GW5074
GW5074 is a chemical compound that acts as a selective inhibitor of the Raf kinase family, particularly targeting the c-Raf isoform. It is primarily used in research settings to study the MAPK/ERK pathway, which is a critical signaling pathway involved in cell division, differentiation, and survival.
Chemical Properties[edit | edit source]
GW5074 is a small molecule with the chemical formula C18H14ClN3O2. It is characterized by its ability to inhibit the activity of Raf kinases, which are serine/threonine-specific protein kinases that play a pivotal role in the MAPK/ERK signaling pathway.
Mechanism of Action[edit | edit source]
GW5074 functions by binding to the ATP-binding site of Raf kinases, thereby preventing the phosphorylation and activation of downstream targets in the MAPK/ERK pathway. This inhibition can lead to the suppression of cell proliferation and induction of apoptosis in certain cancer cell lines, making it a valuable tool for cancer research.
Research Applications[edit | edit source]
GW5074 is widely used in biochemical and cellular assays to investigate the role of Raf kinases in various biological processes. It has been instrumental in elucidating the mechanisms of oncogenesis and the development of targeted cancer therapies.
Cancer Research[edit | edit source]
In cancer research, GW5074 is used to study the effects of Raf inhibition on tumor growth and survival. It has been shown to induce apoptosis in melanoma and glioblastoma cell lines, highlighting its potential as a therapeutic agent.
Neurodegenerative Diseases[edit | edit source]
Beyond oncology, GW5074 has been explored for its effects on neurodegenerative diseases. Studies have suggested that it may have neuroprotective properties, potentially offering benefits in conditions such as Alzheimer's disease and Parkinson's disease.
Safety and Toxicity[edit | edit source]
As with many research chemicals, the safety and toxicity profile of GW5074 is not fully characterized. It is primarily used in vitro and in animal models, and caution is advised when handling the compound.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
